June 2020 – PHAGElogist

Evaluation of various phenotypic methods with genotypic screening for detection of methicillin-resistant Staphylococcus aureus

New publication in Asian Biomedicine, 13(6), 2020. https://doi.org/10.1515/abm-2019-0065 Abstract Background Staphylococcus aureus is one of the common opportunistic gram-positive pathogens which are often associated with nosocomial infections. Detection of methicillin-resistant S. aureus (MRSA)…

Secondary Bacterial Infections During Pulmonary Viral Disease: Phage Therapeutics as Alternatives to Antibiotics?

Secondary bacterial infections manifest during or after a viral infection(s) and can lead to negative outcomes and sometimes fatal clinical complications. Research and development of clinical interventions is largely focused…

What if all viruses disappeared?

If all viruses disappeared, the world would be very different — and not necessarily for the better. But what exactly would happen? Viruses seem to exist solely to wreak havoc…

More about phage therapy-future

Recent Progress by Phage Companies To complement the optimism of the academic research community, a handful of American and European companies are now testing phage-based products in human trials. Different companies are using…

Latest Publication- Access Microbiology

CTX-M-type ESBL-mediated resistance to third-generation cephalosporins and conjugative transfer of resistance in Gram-negative bacteria isolated from hospitals in Tamil Nadu, India https://www.microbiologyresearch.org/content/journal/acmi/10.1099/acmi.0.000142 ABSTRACT Clinical pathogens, especially Gram-negative bacteria developing resistance…

Bacteriophage Therapy Market to grow at a significant rate during 2020-2027

Owing to rising prevalence of antibiotic resistant infection, bacteriophage market to grow in future. Increasing incidence of antimicrobial-resistance is expected to drive growth of the bacteriophage therapy market during the…

How covid-19 is accelerating the threat of antimicrobial resistance

The global threat of antimicrobial resistant bacteria and other superbugs is worsening as many patients admitted to hospital with covid-19 receive antibiotics to keep secondary bacterial infections in check. “Since…

Infectious disease and the need for more options

At this moment in time, all attention has been turned to the novel coronavirus that is circling the globe and upending life as we know it. Not only is the…

Antibiotic Treatment – COVID-19

Published in Nature Microbiology: https://www.nature.com/articles/s41564-020-0739-4 Action is needed to prevent COVID-19 from casting a long shadow over antimicrobial resistance. A peek under the hood of studies reporting on patients hospitalized…

Record number of countries contribute data revealing disturbing rates of antimicrobial resistance

WHO Report: Geneva—A record number of countries are now monitoring and reporting on antibiotic resistance - marking a major step forward in the global fight against drug resistance. But the…